How Gilead is positioning its COVID-19 drug against newer antivirals like Paxlovid
April 27, 2022 at 09:32 AM EDT
The company has an oral version of its COVID-19 drug Veklury in a clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|